What role does CYP2C19 play in skin aging?

CYP2C19 is a cytochrome P450 enzyme primarily involved in drug metabolism (e.g., clopidogrel, omeprazole). There is no robust evidence directly linking CYP2C19 variants to skin aging. The available knowledge, including the well-studied CYP2C19*2 (rs4244285) loss-of-function allele, comes from pharmacogenetics and has not been validated in dermatological or aging contexts. Indirect mechanisms—such as altered detoxification capacity affecting oxidative stress or inflammation—are plausible but remain speculative. No peer-reviewed studies demonstrate that CYP2C19 genotype influences skin aging markers (e.g., wrinkles, elasticity, pigmentation) or response to anti-aging interventions. Consumers should interpret DNA test results for this gene with caution; claims about skin aging are not supported by current evidence. Lifestyle factors (sun protection, diet, smoking) have far greater impact on skin aging than this genetic variant.